Device Therapy for Heart Failure

American Journal of Cardiovascular Drugs - Tập 8 - Trang 147-153 - 2012
Omar F. Shams1, Hector O. Ventura2
1Department of Internal Medicine, Ochsner Medical Center, New Orleans, USA
2Department of Cardiovascular Diseases, Ochsner Medical Center, New Orleans, USA

Tóm tắt

Surgical approaches to heart failure (HF) management have become a necessary strategy in response to a waiting list that is expanding in the face of a limited supply of organ donors. Multiple studies have supported the safety and efficacy of device-based therapy. Among the device-based therapy options, ventricular assist devices (VADs) represent an alternative to heart transplantation with the capability to function as short-term support, bridge-to-transplantation or recovery and as long-term support. VAD support may be considered in those with refractory cardiogenic shock or those with decompensated chronic HF that is unresponsive to maximized medical therapy. Composite scoring scales may be used to risk-stratify patients using clinical and laboratory values to allow more systematic patient selection. As the pursuit for a perfect device continues, so does the search for the best objective index to guide referral. Technologic advances will enhance device performance and extend VAD use into community practice. This discussion aims to highlight criteria for candidate selection and referral for VAD implantation.

Tài liệu tham khảo

American Heart Association. Heart disease and stroke statistics: 2005 update. Dallas (TX): American Heart Association, 2005.

Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics: 2007 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007 Feb 6; 115(5): e69–171.

Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report: 2006. J Heart Lung Transplant 2006 Aug; 25(8): 869–79.

Annual Report of U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1996–2005. Rockville (MD): Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, 2006.

DeRose Jr JJ, Umana JP, Argenziano M, et al. Implantable left ventricular assist devices provide an excellent outpatient bridge to transplantation and recovery. J Am Coll Cardiol 1997 Dec; 30(7): 1773–7.

Leshnower BG, Gleason TG, O’Hara ML, et al. Safety and efficacy of left ventricular assist device support in postmyocardial infarction cardiogenic shock. Ann Thorac Surg 2006 Apr; 81(4): 1365–70.

Yano M, Onitsuka T, Shibata K, et al. Efficacy and safety of a percutaneous right ventricular assist system. Ann Thorac Surg 1996 Apr; 61(4): 1231–5.

Helman DN, Addonizio LJ, Morales DL, et al. Implantable left ventricular assist devices can successfully bridge adolescent patients to transplant. J Heart Lung Transplant 2000 Feb; 19(2): 121–6.

McCarthy PM, James KB, Savage RM, et al. Implantable left ventricular assist device: approaching an alternative for end-stage heart failure. Implantable LVAD Study Group. Circulation 1994 Nov; 90(5 Pt 2): II83–6.

Morales DL, Catanese KA, Helman DN, et al. Six-year experience of caring for forty-four patients with a left ventricular assist device at home: safe, economical, necessary. J Thorac Cardiovasc Surg 2000 Feb; 119(2): 251–9.

Deng MC, Loebe M, El-Banayosy A, et al. Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation 2001 Jan 16; 103(2): 231–7.

LeGallois CJJ. Experience on the principle of life [in French]. Philadelphia (PA): Thomas, 1813.

Farrar DJ. The Thoratec ventricular assist device: a paracorporeal pump for treating acute and chronic heart failure. Semin Thorac Cardiovasc Surg 2000 Jul; 12(3): 243–50.

Vranckx P, Foley DP, de Feijter PJ, et al. Clinical introduction of the Tandemheart, a percutaneous left ventricular assist device, for circulatory support during high-risk percutaneous coronary intervention. Int J Cardiovasc Intervent 2003; 5(1): 35–9.

Kar B, Forrester M, Gemmato C, et al. Use of the Tandemheart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol 2006 Apr; 18(3): 93–6.

Stevenson LW, Kormos RL, Bourge RC, et al. Mechanical cardiac support 2000: current applications and future trial design. June 15–16, 2000, Bethesda, Maryland. J Am Coll Cardiol 2001 Jan; 37(1): 340–70.

McCarthy PM, Smedira NO, Vargo RL, et al. One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology. J Thorac Cardiovasc Surg 1998 Apr; 115(4): 904–12.

Park SJ, Nguyen DQ, Bank AJ, et al. Left ventricular assist device bridge therapy for acute myocardial infarction. Ann Thorac Surg 2000 Apr; 69(4): 1146–51.

Frazier OH, Macris MP, Myers TJ, et al. Improved survival after extended bridge to cardiac transplantation. Ann Thorac Surg 1994 Jun; 57(6): 1416–22.

Myers TJ, Dasse KA, Macris MP, et al. Use of a left ventricular assist device in an outpatient setting. ASAIO J 1994 Jul–Sep; 40(3): M471–5.

Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001 Nov 15; 345(20): 1435–43.

DeBakey ME. Left ventricular bypass pump for cardiac assistance: clinical experience. Am J Cardiol 1971 Jan; 27(1): 3–11.

Cooley DA, Liotta D, Hallman GL, et al. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol 1969 Nov; 24(5): 723–30.

DeVries WC. The permanent artificial heart. Four case reports. JAMA 1988 Feb 12; 259(6): 849–59.

Heerdt PM, Holmes JW, Cai B, et al. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation 2000 Nov 28; 102(22): 2713–9.

Bruckner BA, Stetson SJ, Perez-Verdia A, et al. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant 2001 Apr; 20(4): 457–64.

Vatta M, Stetson SJ, Perez-Verdia A, et al. Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistancedevice therapy. Lancet 2002 Mar 16; 359(9310): 936–41.

Xydas S, Rosen RS, Ng C, et al. Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery. J Heart Lung Transplant 2006 Jan; 25(1): 7–15.

Ogletree-Hughes ML, Stull LB, Sweet WE, et al. Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation 2001 Aug 21; 104(8): 881–6.

James KB, McCarthy PM, Thomas JD, et al. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation 1995 Nov 1; 92(9 Suppl.): II191–5.

Pietsch L, Laube H, Baumann G, et al. Recovery from end-stage ischemic cardiomyopathy during long-term LVAD support. Ann Thorac Surg 1998 Aug; 66(2): 555–7.

Frazier OH, Benedict CR, Radovancevic B, et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 1996 Sep; 62(3): 675–81.

Nguyen DQ, Ormaza S, Miller LW, et al. Left ventricular assist device support for medically unresponsive pulmonary hypertension from left ventricular failure [abstract]. J Heart Lung Transplant 2001 Feb; 20(2): 190.

Petrofski JA, Hoopes CW, Bashore TM, et al. Mechanical ventricular support lowers pulmonary vascular resistance in a patient with congenital heart disease. Ann Thorac Surg 2003 Mar; 75(3): 1005–7.

Loebe M, Muller J, Hetzer R. Ventricular assistance for recovery of cardiac failure. Curr Opin Cardiol 1999 May; 14(3): 234–48.

Hetzer R, Muller JH, Weng Y, et al. Bridging-to-recovery. Ann Thorac Surg 2001 Mar; 71(3 Suppl.): S109–13.

Muller J, Wallukat G, Weng YG, et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 1997 Jul 15; 96(2): 542–9.

Frazier OH, Myers TJ. Left ventricular assist system as a bridge to myocardial recovery. Ann Thorac Surg 1999 Aug; 68(2): 734–41.

Birks EJ, Tansley PD, Hardy J, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. New Engl J Med 2006 Nov 2; 355(18): 1873–84.

George I, Xydas S, Mancini DM, et al. Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support. J Heart Lung Transplant 2006 Sep; 25(9): 1084–90.

Bank AJ, Mir SH, Nguyen DQ, et al. Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation. Ann Thorac Surg 2000 May; 69(5): 1369–74.

Aaronson KD, Patel H, Pagani FD. Patient selection for left ventricular assist device therapy. Ann Thorac Surg 2003 Jun; 75(6 Suppl.): S29–35.

Hausmann H, Potapov EV, Koster A, et al. Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score. Circulation 2002 Sep 24; 106(12 Suppl. 1): 1203–6.

DiGiorgi PL, Rao V, Naka Y, et al. Which patient, which pump? J Heart Lung Transplant 2003 Mar; 22(3): 221–35.

Norman JC, Cooley DA, Igo SR, et al. Prognostic indices for survival during postcardiotomy intra-aortic balloon pumping: methods of scoring and classification, with implications for left ventricular assist device utilization. J Thorac Cardiovasc Surg 1977 Nov; 74(5): 709–20.

Aaronson KD, Schwartz JS, Chen TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997 Jun 17; 95(12): 2660–7.

Kormos RL, Gasior TA, Kawai A, et al. Transplant candidate’s clinical status rather than right ventricular function defines need for univentricular versus biventricular support. J Thorac Cardiovasc Surg 1996 Apr; 111(4): 773–82.

Loebe M, Koerner MM, Lafuente JA, et al. Patient selection for assist devices: bridge to transplant. Curr Opin Cardiol 2003 Mar; 18(2): 141–6.

Felker GM, Rogers JG. Same bridge, new destinations rethinking paradigms for mechanical cardiac support in heart failure. J Am Coll Cardiol 2006 Mar 7; 47(5): 930–2.

Stevenson LW. Patient selection for mechanical bridging to transplantation. Ann Thorac Surg 1996 Jan; 61(1): 380–7.

Miller LW, Lietz K. Candidate selection for long-term left ventricular assist device therapy for refractory heart failure. J Heart Lung Transplant 2006 Jul; 25(7): 756–64.

Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005 Sep 20; 112(12): e154–235.

Ochiai Y, McCarthy PM, Smedira NG, et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 2002 Sep 24; 106(12 Suppl. 1): I198–202.

Rao V, Oz MC, Flannery MA, et al. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg 2003 Apr; 125(4): 855–62.

Swartz MT, Votapka TV, McBride LR, et al. Risk stratification in patients bridged to cardiac transplantation. Ann Thorac Surg 1994 Oct; 58(4): 1142–5.

Farrar DJ. Preoperative predictors of survival in patients with Thoratec ventricular assist devices as a bridge to heart transplantation: Thoratec Ventricular Assist Device Principal Investigators. J Heart Lung Transplant 1994 Jan–Feb; 13(1 Pt 1): 93–100.

Reinhartz O, Farrar DJ, Hershon JH, et al. Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation. J Thorac Cardiovasc Surg 1998 Oct; 116(4): 633–40.

Miller LW. Patient selection for the use of ventricular assist devices as a bridge to transplantation. Ann Thorac Surg 2003 Jun; 75(6 Suppl.): S66–71.

Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997 Apr 12; 349(9058): 1050–3.

Dang NC, Topkara VK, Kim BT, et al. Nutritional status in patients on left ventricular assist device support. J Thorac Cardiovasc Surg 2005 Nov; 130(5): e3–4.

Holdy K, Dembitsky W, Eaton LL, et al. Nutrition assessment and management of left ventricular assist device patients. J Heart Lung Transplant 2005 Oct; 24(10): 1690–6.

Zimpfer D, Wieselthaler G, Czerny M, et al. Neurocognitive function in patients with ventricular assist devices: a comparison of pulsatile and continuous blood flow devices. ASAIO J 2006; 52: 24–7.

Gracin N, Johnson MR, Spokas D, et al. The use of APACHE II scores to select candidates for left ventricular assist device placement: acute physiology and chronic health evaluation. J Heart Lung Transplant 1998 Oct; 17(10): 1017–23.

Thông tin
Thông tin xuất bản

American Journal of Cardiovascular Drugs

Tập 8

147-153

Thông tin tác giả